VTYX Stockholders are Encouraged to Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Ventyx Biosciences, Inc. Class Action Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug

VTYX Stockholders with Large Losses Should Contact Robbins LLP to Learn More about the Ventyx Biosciences, Inc. Class Action Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug

VTYX STOCKHOLDER NEWS: Contact Robbins LLP for Information Regarding the Ventyx Biosciences, Inc. Class Action Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug